Lin Shen - Publications, H-index & Citations

Lin Shen

Peking University Cancer Hospital & Institute

62H指数

825论文数

2.7W被引数

收录论文 236

发表时间

Efficacy and Safety of DVDMS-Photodynamic Therapy for Dysphagia in Advanced Esophageal Cancer: A Phase II Clinical Trial 晚期食管癌吞咽困难患者中DVDMS-光动力疗法的安全性和有效性：一项II期临床试验

Cancer Science

IF4.3

2026-09-06

OAAI

Jun Zhou; Shegan Gao; Jiajia Yuan; Hao Chen; Yongqian Shu; Huizhen Fan; Yanshuo Cao; Tanyou Shan; Caihong Dong; Hao Zhang; Qingting Song; Baobao Xin; Zhihao Lu; Lin Shen

Identification of factors conferring resistance to trastuzumab deruxtecan in advanced gastric cancer: a translational study from the single-arm, phase II, DESTINY-Gastric06 trial 张斌; 张磊; 刘晨; 谢天; 张颖; 吴鑫; 陈宇; 程思; 冯毅; 王颖; 等. 识别导致曲妥珠单抗德鲁克替康耐药的因素：来自单臂、II期、DESTINY-Gastric06试验的转化研究. 精准临床医学. 2026, 9, pbaf038. [谷歌学术] [CrossRef] [PubMed]

Precision Clinical Medicine

IF5

2026-03-01

PREAI

Zhang, Bohan; Zhang, Lei; Liu, Cheng; Xie, Tong; Zhang, Yifan; Wu, Xiao; Chen, Yining; Cheng, Siyuan; Feng, Yang; Wang, Yuxin; Gao, Erke; Zhang, Hongquan; Shen, Lin; Peng, Zhi; Wei, Xiaofan

A phase 1b/2 study of first-line anti-PD-L1/ TGF-βRII fusion protein SHR-1701 combined with nab-paclitaxel and gemcitabine for advanced pancreatic ductal adenocarcinoma 一线anti-PD-L1/tgf-βrii融合蛋白SHR-1701联合白蛋白结合型紫杉醇和吉西他滨治疗晚期胰腺导管腺癌的1b/2期研究

Signal Transduction and Targeted Therapy

IF52.7

2025-12-20

OAAI

Ran Xue; Miaoyan Wei; Jiajia Yuan; Zhihua Li; Yuhong Zhou; Zeyun Xue; Yiwen Wu; Hongxia Han; Jun Zhou; Xianjun Yu; Lin Shen

Chinese expert consensus on diagnosis and treatment of small gastrointestinal stromal tumors (2025 edition)《小胃肠间质瘤（2025年版）诊断与治疗中国专家共识》

Cancer

IF5.1

2025-12-09

OAAI

Zhidong Gao MD; Chao Wang MD; Jian Li MD; Peng Zhang MD; Xin Wu MD; Yi Wang MD; Liming Zhang MD; Tao Chen MD; Bo Zhang MD; Ming Wang MD; Haoran Qian MD; Ye Zhou MD; Shijie Li MD; Yan Sun MD; Han Liang MD; Yulong He MD; Yong Li MD; Hui Cao MD; Shukui Qin MD; Lin Shen MD; Yingjiang Ye MD, PhD; Chinese Society of Clinical Oncology (CSCO) Expert Committee on Gastrointestinal Stromal Tumor

Comparative efficacy and safety of teriparatide versus bisphosphonates in osteoporosis: a meta-analysis 特立帕肽与双膦酸盐治疗骨质疏松症的疗效与安全性比较：一项荟萃分析

FRONTIERS IN SURGERY

IF1.8

2025-12-08

OAAI

Jin, Huan; Dong, Ying; Huang, Cai; Wang, Di; He, Ziyi; Shen, Lin; Ma, Chen; Wang, Zixian; Shi, Siwei; Shuai, Bo

Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 study 帕博利珠单抗联合化疗与化疗对比治疗晚期食管癌：KEYNOTE-590随机III期研究的5年扩展随访

ESMO Open

IF8.3

2025-11-18

OAAI

J.-P. Metges; K. Kato; J.-M. Sun; L. Shen; P.C. Enzinger; A. Adenis; T. Doi; T. Kojima; Z. Li; S.-B. Kim; B.C. Cho; W. Mansoor; S.-H. Li; P. Sunpaweravong; M. Alsina; G.L. Buchschacher; H. Hara; A. Tsuji; J. Wu; S. Shah

Nab-paclitaxel plus bevacizumab for patients with metastatic extrapulmonary neuroendocrine carcinoma: a phase 2 single-arm study Nab-紫杉醇联合贝伐珠单抗治疗转移性肺外神经内分泌癌：一项单臂Ⅱ期研究

eClinicalMedicine

IF10

2025-10-24

OAAI

Panpan Zhang; Shengmian Li; Ru Jia; Jing Hao; Chen Chen; Shilin Gan; Jie Li; Lin Shen; Ming Lu

Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials glecirasib在KRAS G12C突变实体瘤中的有效性和安全性：两项I/II期试验的合并分析

Cancer Communications

IF24.9

2025-10-02

OAAI

Jian Li; Ting Deng; Yanhong Gu; Antonio Calles Blanco; Zhihua Li; Chunmei Bai; Lin Wu; Jing Huang; Xingya Li; Yu Yao; Zhengbo Song; Yongsheng Li; Lian Liu; Ligang Xing; Wenming Wu; Julia Martínez-Pérez; Ayala Hubert; Jon Zugazagoitia; Jian Zhang; Yongsheng Wang; Yanqiu Zhao; Guilan Wen; Guohao Xia; Diansheng Zhong; Xueqin Chen; Kuirong Jiang; Andrea Wang-Gillam; Yuli Ding; Sumei Liu; Zhiyue Rao; Xinghu Liu; Lin Shen

Trastuzumab deruxtecan in patients from China with previously treated human epidermal growth factor receptor 2–positive locally advanced/metastatic gastric or gastroesophageal junction adenocarcinoma (DESTINY-Gastric06): results from a single-arm, multicenter, phase 2 trial 曲妥珠单抗德鲁替康在既往接受过治疗的中国人表皮生长因子受体2阳性局部晚期/转移性胃或胃食管结合部腺癌患者中的疗效（DESTINY-Gastric06）：一项单臂、多中心、II期试验的结果

eClinicalMedicine

IF10

2025-08-11

PREAI

Zhi Peng; Ping Chen; Jin Lu; Yiye Wan; Yulong Zheng; Feng Ye; Jianwei Yang; Ying Liu; Hongming Pan; Meili Sun; Qingxia Fan; Ying Yuan; Kai Chen; Zhuoer Sun; Han Tian; Ye Xia; Lin Shen

ESG practices and financing constraints of Chinese high-carbon enterprises under carbon reduction pressure: The role of credit financing and corporate reputation 碳减排压力下中国高碳企业的ESG实践与融资约束：信贷融资与公司声誉的作用

Economic Modelling

IF4.7

2025-07-29

PREAI

Lin Shen; Wen Zhang; Dan Ma

Comparison of efficacy and safety of combined phacoemulsification; goniosynechialysis and goniotomy with trabeculectomy in advanced primary angle-closure glaucoma: a retrospective observational study 比较联合白内障超声乳化术、虹膜根部分离松解术和前房角切开术与 Trabeculectomy 在治疗晚期原发性闭角型青光眼中的疗效与安全性：一项回顾性观察性研究

Frontiers in Medicine

IF3

2025-07-23

OAAI

Wenzhe Zhang†; Pengyun Wang†; Chen Wang; Wenhui Liu; Jiayin Wu; Lin Shen; Rachita Kurmi; Hui Guo

CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial CLDN18.2靶向抗体-药物偶联物IBI343治疗晚期胃或胃食管交界处腺癌: 1期试验

Nature Medicine

IF50

2025-07-16

OAAI

Jia Liu; Jianwei Yang; Yuping Sun; Jifang Gong; Jinbo Yue; Yueyin Pan; Meili Sun; Rongfeng Song; Xiuying Xiao; Andrea Tazbirkova; Jian Ruan; Zhenyang Liu; Zimin Liu; Zhihua Li; Lili Sheng; Yanru Qin; Jieer Ying; Xianjun Yu; Jian Zhang; Yiping Mou; Chuangxin Lu; Ping Chen; Suyi Li; Jie Li; Xiujuan Qu; Ting Deng; Juan Du; Aiping Zhou; Enxiao Li; Xianglin Yuan; Xinjun Liang; Weiming Yu; Michelle Morris; Yang Luo; Xin Zhao; Yingmei Guo; Hui Zhou; Lin Shen

Fruquintinib in less pretreated patients: multivariate profile-matching analysis of FRESCO-2 to FRESCO fruquintinib 在较少预治疗患者中的研究：FRESCO-2 与 FRESCO 的多变量配型匹配分析

European Journal of Cancer

IF7.1

2025-07-13

OAAI

Arvind Dasari; Cathy Eng; Sara Lonardi; Rocio Garcia-Carbonero; Toshiki Masuishi; Chiara Cremolini; François Ghiringhelli; Joleen Hubbard; Tanios Bekaii-Saab; Jeremy Jones; Rui-Hua Xu; Lin Shen; Jianming Xu; Yuxian Bai; Yanhong Deng; Ying Yuan; Wei Wei; Jianchang Lin; Lucy Chen; Zhao Yang; Jin Li

An Image-Based Model for Assisting in Diagnosing Malignant Esophageal Lesions During Lugol Chromoendoscopic Examination 一种基于图像的模型，用于在卢戈氏碘染色内镜检查期间辅助诊断恶性食管病变

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY

IF3

2025-05-01

OAAI

Liu, Mengfei; Qi, Zifan; Zhou, Ren; Guo, Chuanhai; Liu, Anxiang; Yang, Haijun; Li, Fenglei; Duan, Liping; Shen, Lin; Wu, Qi; Liu, Zhen; Pan, Yaqi; Liu, Fangfang; Liu, Ying; Chen, Huanyu; Hu, Zhe; Cai, Hong; He, Zhonghu; Ke, Yang

Autologous glueless simple oral mucosal transplantation for the repair of limbal stem cell deficiency ocular surface in a rabbit model

SCIENTIFIC REPORTS

IF3.9

2025-03-29

OAAI

Zhang, Kai; Liu, Wei; Ren, Xiaoxiao; Yin, Yiqiang; Chen, Wenming; Chen, Fen; Zhu, Jing; Shen, Lin

Targeting novel immune checkpoints in the B7-H family: advancing cancer immunotherapy from bench to bedside 靶向B7-H家族中的新型免疫检查点：推动癌症免疫疗法从实验室到临床应用

Trends in Cancer

IF17.5

2025-03-19

OAAI

Yiming Luo; Ye Yuan; Dan Liu; Haoxin Peng; Lin Shen; Yang Chen

M6A-modified BFSP1 induces aerobic glycolysis to promote liver cancer growth and metastasis through upregulating tropomodulin 4 M6A修饰的BFSP1通过上调tropomodulin 4诱导有氧糖酵解，以促进肝癌的生长和转移。

MOLECULAR BIOMEDICINE

IF10.1

2025-03-18

OAAI

Li, Rong; Li, Shunle; Shen, Lin; Li, Junhui; Zhang, Di; Yu, Jinmin; Huang, Lanxuan; Lu, Hongwei; Xu, Meng

Absolute Risk Prediction for Esophageal Squamous Cell Carcinoma Adaptable to Regional Disease Burden across Diverse Regions

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2025-02-13

PREAI

Liu, Mengfei; Huang, Yi; Tian, Hongrui; Guo, Chuanhai; Liu, Zhen; Liu, Anxiang; Yang, Haijun; Li, Fenglei; Duan, Liping; Shen, Lin; Wu, Qi; Shi, Chao; Pan, Yaqi; Liu, Fangfang; Liu, Ying; Chen, Huanyu; Hu, Zhe; Cai, Hong; He, Zhonghu; Ke, Yang

Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centers

CANCER BIOLOGY & MEDICINE

IF8.4

2025-01-17

OAAI

Lu, Zhihao; Geng, Mingfei; Han, Yongtao; Cao, Jianzhong; Wang, Jun; Liu, Tianshu; Yuan, Xianglin; Meng, Xue; Zhang, Yanqiao; Zhao, Rong; Wan, Lixin; Li, Enxiao; Wang, Wenran; Li, Zhijie; Shi, Danfeng; Qian, Jing; Shi, Si; Dong, Fengshi; Shen, Lin

Tinengotinib (TT-00420) in combination with atezolizumab (atezo) in Chinese patients (pts) with biliary tract carcinoma (BTC): Efficacy and safety results from a phase Ib/II study Tinengotinib (TT-00420) 联合阿替利珠单抗 (atezo) 治疗中国胆道癌 (BTC) 患者的疗效和安全性结果：一项 Ib/II 期研究

ANNALS OF ONCOLOGY

IF65.4

2024-12-01

PREAI

Zhang, P.; Gong, J.; Niu, Z.; Cheng, Y.; Cao, B.; Hou, X.; Fan, J.; Peng, P.; Sun, C. A.; Wang, H.; Yu, Y.; Zhu, Y.; Li, Q.; Huang, P.; Wu, F.; Shen, L.

研究方向